- Home
- GNPX vs GORV Comparison
GNPX vs GORV Comparison
Compare GNPX & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- GORV
- Stock Information
- Founded
- GNPX 2009
- GORV 1976
- Country
- GNPX United States
- GORV United States
- Employees
- GNPX N/A
- GORV N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- GNPX Health Care
- GORV Consumer Discretionary
- Exchange
- GNPX Nasdaq
- GORV Nasdaq
- Market Cap
- GNPX 10.8M
- GORV 9.3M
- IPO Year
- GNPX 2018
- GORV 2015
- Fundamental
- Price
- GNPX $2.97
- GORV $0.44
- Analyst Decision
- GNPX
- GORV
- Analyst Count
- GNPX 0
- GORV 0
- Target Price
- GNPX N/A
- GORV N/A
- AVG Volume (30 Days)
- GNPX 299.4K
- GORV 656.9K
- Earning Date
- GNPX 11-14-2025
- GORV 11-14-2025
- Dividend Yield
- GNPX N/A
- GORV N/A
- EPS Growth
- GNPX N/A
- GORV N/A
- EPS
- GNPX N/A
- GORV N/A
- Revenue
- GNPX N/A
- GORV $558,425,000.00
- Revenue This Year
- GNPX N/A
- GORV $15.65
- Revenue Next Year
- GNPX N/A
- GORV $20.54
- P/E Ratio
- GNPX N/A
- GORV N/A
- Revenue Growth
- GNPX N/A
- GORV N/A
- 52 Week Low
- GNPX $2.77
- GORV $0.42
- 52 Week High
- GNPX $63.00
- GORV $33.00
- Technical
- Relative Strength Index (RSI)
- GNPX 42.93
- GORV 24.71
- Support Level
- GNPX $2.77
- GORV $0.70
- Resistance Level
- GNPX $5.00
- GORV $1.19
- Average True Range (ATR)
- GNPX 0.48
- GORV 0.23
- MACD
- GNPX -0.27
- GORV -0.05
- Stochastic Oscillator
- GNPX 8.07
- GORV 0.50
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.